Cargando…
High efficacy of gemifloxacin-containing therapy in Helicobacter Pylori eradication: A pilot empirical second-line rescue therapy
BACKGROUND: Helicobacter pylori (H pylori) is a common gastric pathogen which is associated with chronic gastritis, peptic ulcer, and gastric cancer. It has worldwide distribution with higher incidence in developing countries. Gemifloxacin is a fluoroquinolone antibiotic with documented in vitro act...
Autores principales: | Mahmoudi, Laleh, Farshad, Shohreh, Seddigh, Mehrdad, Mahmoudi, Paria, Ejtehadi, Fardad, Niknam, Ramin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079309/ https://www.ncbi.nlm.nih.gov/pubmed/27759625 http://dx.doi.org/10.1097/MD.0000000000004410 |
Ejemplares similares
-
Prevalence of Helicobacter pylori in Patients With Dyspepsia
por: Niknam, Ramin, et al.
Publicado: (2014) -
Helicobacter pylori, Endoscopic, And Histologic Features Among Kidney Transplant Candidates In Southern Iran
por: Niknam, Ramin, et al.
Publicado: (2019) -
Clarithromycin versus Gemifloxacin in Quadruple Therapeutic Regimens for Helicobacter Pylori Infection Eradication
por: Mansour-Ghanaei, Fariborz, et al.
Publicado: (2017) -
Association Between Metabolic Syndrome and Its Components with Severity of Acute Pancreatitis
por: Niknam, Ramin, et al.
Publicado: (2020) -
Self-medication of irritable bowel syndrome and dyspepsia: How appropriate is it?
por: Niknam, Ramin, et al.
Publicado: (2016)